The FDA is considering expanding the definition of what can be considered a nonprescription drug. The reasoning behind the possible new policy is the FDA wants to streamline healthcare. Studies have found that up to 20% of patients will not get prescriptions filled or they will not return to a physician to get prescriptions for refills. Moving some of the most common medications to nonprescription status would decrease the number of visits to physicians and may increase the likelihood that patients who need these medications will get them. [continue reading…]
{ 0 comments }